Stay informed with the latest updates for the inheritable blood disorders community.

Advocacy & Legislative
NHF & HFA Respond to New Blue Cross Blue Shield of Tennessee Formularies…
Industry
Scientist Pipetting Liquids for Research
New FIX Chromogenic Assay Launched by Precision BioLogic
Industry
Biomarin Provides Hemophilia A Clinical Development Program Updates
Biomarin Provides Hemophilia A Clinical Development Program Updates
Industry
Takeda Announces Trial Results on Investigational Therapy for Ultra Rare Blood Disorder
Takeda Announces Trial Results on Investigational Therapy for…
Press Releases
NHF Announces 2023 Winter/Spring Wednesday Webinar Schedule
Industry
Image of a blue gene helix with a red section in the center
Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy…
Press Releases
NBDF and HFA Address Concerns on WHO's Recommendation of Cryoprecipitate
NHF Assumes Leadership of the American Plasma Users Coalition
NBDF & Community
Own Your Path
NHF's Own Your Path program begins recruitment
Industry
Clinical Trial Lab Research
Spark Announces SPK-8011 Updates at ASH
Press Releases
75th Anniversary
National Hemophilia Foundation Set to Celebrate 75 Years in 2023
Medical
gene therapy
First Hemophilia B Gene Therapy Approved by FDA
Press Releases
Giving Shoesday Event Banner
NHF kicks off the season of giving with Giving Shoesday
Medical
New Document to Help Residential Substance Use Disorder Placement for Individuals with Bleeding Disorders
New Document to Help Residential Substance…
Press Releases
JGP 50 years
National Hemophilia Foundation Celebrates 50 Years of the…
NBDF & Community
Continued Conversation on the State of Access to Women’s Health Care
Continued Conversation on the State of Access to Women’s Health Care